Key Studies Influencing My Practice Following IAS 2021—Audio Recap - a podcast by Clinical Care Options

In this episode, Babafemi Taiwo, MBBS, discusses new HIV data from IAS 2021, including:

• WHO Global Clinical Platform: COVID-19 outcomes in PWH
• 2-drug regimen of DTG/3TC: efficacy, metabolic outcomes (TANGO)
• Investigational antiretroviral use
  • CAB LA + RPV LA in treatment-naive PWH (FLAIR)
• Investigational antiretroviral agents
  • LEN (CAPELLA, CALIBRATE)
  • ISL (P011, P016)
• Alternative BPaL dosing in treatment of drug-resistant TB (ZeNix)

Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Content based on a CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP.; Merck Sharp & Dohme Corp; and ViiV Healthcare.

Follow along with an expanded slideset at: 
https://bit.ly/3syWD5T

Link to full program: 
https://bit.ly/3z8SBnC

Further episodes of CCO Infectious Disease Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options